Mikael Herlevsen

Director, IP at Rivus Pharmaceuticals - Charlottesville, Virginia, United States

Mikael Herlevsen's Colleagues at Rivus Pharmaceuticals
Allen Cunningham

President and CEO, Rivus Pharmaceuticals, Inc.

Contact Allen Cunningham

Mikael Herlevsen's Contact Details
HQ
(202) 430-9762
Location
Charlottesville,Virginia,United States
Company
Rivus Pharmaceuticals
Mikael Herlevsen's Company Details
Rivus Pharmaceuticals logo, Rivus Pharmaceuticals contact details

Rivus Pharmaceuticals

Charlottesville, Virginia, United States • 4 Employees
Research

Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators (CMAs). Rivus' CMAs are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (HFpEF). For more information please visit https://www.rivuspharma.com/

Details about Rivus Pharmaceuticals
Frequently Asked Questions about Mikael Herlevsen
Mikael Herlevsen currently works for Rivus Pharmaceuticals.
Mikael Herlevsen's role at Rivus Pharmaceuticals is Director, IP.
Mikael Herlevsen's email address is ***@rivuspharma.com. To view Mikael Herlevsen's full email address, please signup to ConnectPlex.
Mikael Herlevsen works in the Research industry.
Mikael Herlevsen's colleagues at Rivus Pharmaceuticals are Jayson Dallas, Allen Cunningham and others.
Mikael Herlevsen's phone number is (202) 430-9762
See more information about Mikael Herlevsen